VA gets new lung-imaging tool to diagnose veteran respiratory disease
H.R. 9666 — AIR CARE for Vets Act of 2026 · Filed by Juan Ciscomani (R-AZ) · 2 cosponsors · Introduced Jul 14, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the VA to run a 5-year pilot program using FDA-approved 4D lung imaging software to detect respiratory disorders and lung disease in veterans. The VA will lease the software from a private developer, spend up to $5 million per year (2027–2031), and report back to Congress on whether it works. Veterans with lung problems get earlier, better diagnosis; the software company gets a guaranteed federal customer.
Why we flagged it
The bill's core function is establishing a time-limited, evidence-based pilot to test a specific diagnostic technology for a veteran population. It is not a permanent entitlement, not a broad deregulation, and not a carve-out — it is a targeted pilot with built-in evaluation and sunset.
What the text implies
- The bill does not specify competitive bidding or price controls; the VA may negotiate with a single vendor, creating potential for above-market lease rates if the software is proprietary or sole-source.
- The 5-year pilot expires before the 2-year post-pilot report is due, meaning Congress will not receive evaluation data until 2 years after the program ends — a gap that could delay scaling or termination decisions.
The full analysis lists 4 implications of this text.
Who stands to gain
4D lung imaging software developers/vendors; Medical device companies with FDA-approved respiratory imaging products